Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
gptkb:drug cytokine |
| gptkbp:administeredBy |
injection
|
| gptkbp:affiliatedWith |
type I interferon family
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L03AB04
|
| gptkbp:CASNumber |
76543-88-9
|
| gptkbp:discoveredIn |
1980s
|
| gptkbp:encodedBy |
IFNA2 gene
|
| gptkbp:hasMolecularFormula |
C860H1353N229O255S9
|
| gptkbp:hasUNII |
P0A3F4
|
| https://www.w3.org/2000/01/rdf-schema#label |
Interferon alpha-2A
|
| gptkbp:marketedAs |
gptkb:Roferon-A
|
| gptkbp:mechanismOfAction |
inhibits viral replication
modulates immune response |
| gptkbp:producedBy |
recombinant DNA technology
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201562
gptkb:DB00034 D08144 16129629 |
| gptkbp:sideEffect |
gptkb:depression
gptkb:anemia fatigue flu-like symptoms |
| gptkbp:synonym |
gptkb:Roferon-A
gptkb:IFN-alpha-2A recombinant interferon alpha-2A |
| gptkbp:usedFor |
gptkb:chronic_myelogenous_leukemia
gptkb:hairy_cell_leukemia gptkb:Kaposi's_sarcoma gptkb:chronic_hepatitis_C chronic hepatitis B |
| gptkbp:bfsParent |
gptkb:DB00021
|
| gptkbp:bfsLayer |
7
|